(2) This study figured out that blood MALT1 had the potential to predict treatment response to systemic biologic therapy in psoriasis patients, which indicated that blood MALT1 participated in the process of systemic biologic therapy in attenuating psoriasis activity; however, this speculation was warranted to validate. The gene discussed is MALT1; the disease is psoriasis.